8:52
Learn More About Windtree Therapeutics (NASDAQ: $WINT) And Their Treatment For Cardiogenic Shock
Benzinga Partner Studio
7:17
Windtree Therapeutics (NASDAQ: $WINT): What Is SERCA2a And Why Is It Important?
10:14
Unveiling The Potential Of Istaroxime W/ Windtree Therapeutics' SEISMiC Extension Study
9:31
Windtree Therapeutics $WINT Announces Positive Phase 2b Results In Early Cardiogenic Shock Treatment
